| Category | Specification |
| Test Method | Fluorescent immunochromatography |
| Reagent Position | 6 (equipped with dehumidification function) |
| Sample Position | 30 |
| Emergency Position | 1 |
| Pipetting Mode | Disposable Tip |
| Sample Type | Serum, plasma, whole blood |
| Sample Tube Type | Blood collection tubes, centrifuge tubes |
| Tip/mixed well | 2*96/2*48 |
| Test Item | Sample Type/Volume | Reaction Time | Detection Range | Qualification |
|---|---|---|---|---|
| Inflammation | ||||
| PCT | Serum, plasma, whole blood, 60μL | 8 min | 0.05-100.00ng/mL | NMPA |
| CRP | Serum, plasma, whole blood, 60μL | 2 min | 0.50-200.00mg/L | NMPA |
| IL-6 | Serum, plasma, whole blood, 60μL | 8 min | 2.50-4000.00 pg/mL | NMPA |
| PCT-CRP | Serum, plasma, whole blood, 60μL | 8 min | PCT:0.05-100.00ng/mL CRP:0.50-200.00mg/L |
NMPA |
| SAA | Serum, plasma, whole blood, 60μL | 2 min | 5.00-250.00mg/L | NMPA |
| CRP-SAA | Serum, plasma, whole blood, 60μL | 2 min | CRP: 0.50-200.00mg/L SAA: 5.00-250.00mg/L |
NMPA |
| Cardiac Marker | ||||
| hs-cTnl | Serum, plasma, whole blood, 60μL | 8 min | 0.02-80.00 ng/mL | NMPA |
| MYO | Serum, plasma, whole blood, 60μL | 8 min | 21-1000ng/mL | NMPA |
| BNP | Plasma, whole blood, 60μL | 8 min | 15-5000pg/mL | NMPA |
| NT-proBNP | Serum, plasma, whole blood, 60μL | 8 min | 30-35000pg/mL | NMPA |
| CK-MB | Serum, plasma, whole blood, 60μL | 8 min | 0.3-300ng/mL | NMPA |
| D-Dimer | Serum, plasma, whole blood, 60μL | 8 min | 0.05-10ng/mL | NMPA |
| Comb Tests for cTnl, CK-MB & MYO |
Serum, plasma, whole blood, 80μL | 8min | hs-cTnl: 0.02-80.00ng/mL CK-MB: 0.3-300ng/mL MYO: 21-1000ng/mL |
NMPA |
| Hormones | ||||
| β-HCG | Serum, plasma, whole blood, 60μL | 8 min | 2-200000mIU/mL | NMPA |
| Tumour Marker | ||||
| PGI&PG II | Serum, plasma, whole blood, 60μL | 8 min | PG I:1.00-200.00mg/mL PG II: 0.5-100.00mg/mL |
NMPA |
